Mycobacteria produce an unusual, glycolylated form of muramyl dipeptide (MDP) that is more potent and efficacious at inducing NOD2-mediated host responses. We tested the importance of this modified form of MDP in Mycobacterium tuberculosis by disrupting the gene, namH, responsible for this modification. In vitro, the namH mutant did not produce N-glycolylated muropeptides, but there was no alteration in colony morphology, growth kinetics, cellular morphology, or mycolic acid profile. Ex vivo, the namH mutant survived and replicated normally in murine and human macrophages, yet induced diminished production of tumor necrosis factor α. In vivo, namH disruption did not affect the bacterial burden during infection of C57BL/6 mice or cellular recruitment to the lungs but modestly prolonged survival after infection in Rag1 −/− mice. These results indicate that the modified MDP is an important contributor to the unusual immunogenicity of mycobacteria but has a limited role in the pathogenesis of M. tuberculosis infection.
The intracellular receptor NOD2, a member of the Nod-like receptor family, mediates the host innate response to bacterial peptidoglycan (PGN)-derived muramyl dipeptide (MDP). Studies by different groups have shown that the most commonly encountered form of MDP, called N-acetyl MDP, acts upon NOD2, leading to polyubiquitination of the RIP2 kinase, activation of the NF-kB pathway, and ultimately the production of proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-α) [1, 2] . Recently, direct interaction between NOD2 and MDP was shown using surface plasmon resonance, solidifying the notion that MDP is the ligand for the NOD2 receptor [3] .
Mycobacterial PGN is unique in that the N-acetyl group at the carbon 2 of the muramic acid is preferentially hydroxylated to an N-glycolyl group through action of the enzyme N-acetyl muramic acid hydroxylase (NamH) [4] . Because the organisms that have this unusual PGN modification were those used by Jules Freund to produce his eponymous adjuvant [5] , we previously tested whether this modification contributes to the immunogenicity of the mycobacterial cell wall components, by disrupting the namH gene in Mycobacterium smegmatis. NOD2-mediated host responses were blunted in the absence of bacterial namH and additionally, synthetic N-glycolyl MDP was more potent and efficacious at inducing NOD2-mediated responses, both in vitro and in vivo [6] .
Whereas these previous studies in part explain the immunogenicity of inactivated mycobacteria, the use of M. smegmatis, an avirulent saprophyte, precluded us from understanding the importance of this modification for Mycobacterium tuberculosis, a professional pathogen that causes tuberculosis. The pathogenesis of tuberculosis requires a fine balance between bacterial survival (often conceived of as immune evasion) and bacterial transmission (which requires bacterial-induced immunopathology). Because the MDP modification results in enhanced early immune recognition via NOD2, one can envision that a more potent MDP might result in impaired bacterial persistence in the host cell. Yet, an investigation of the conserved genetic elements in 100 different M. tuberculosis clinical isolates revealed that namH was intact in all cases [7] , suggesting selection in favor of this modification. Alternatively, the modification of PGN to favor host immune recognition is advantageous for the bacterium, either early in infection (when the bacteria induces recruitment of host cells to the site of infection) or at the end (when the bacteria converts the lung into an atomizer for transmission to the next host).
Given these competing possibilities, we have investigated the importance of this PGN modification in M. tuberculosis through the disruption of the namH gene and its complementation. Through a combination of in vitro, ex vivo, and in vivo experiments, we confirm that the NOD2-mediated responses are critically dependent on the presence of N-glycolylated PGN, yet, in a whole animal model, the effect of this disruption on the course of M. tuberculosis is modest, at best.
MATERIALS AND METHODS

Bacterial Strains, Growth Conditions, Electroporation Techniques, and Reagents
The stock of M. tuberculosis H37Rv was derived from a strain originally obtained from the Pasteur Institute (Paris, France). All strains of M. tuberculosis were grown at 37°C in Middlebrook 7H9 medium (Difco) supplemented with 10% albumindextrose-catalase (ADC; BD Biosciences), 0.05% tween 80 (Sigma-Aldrich), and 0.2% glycerol, or on 7H11 agar (Difco) supplemented with 10% oleic acid-supplemented ADC (BD Biosciences) and 0.2% glycerol. Hygromycin B (50 μg/mL; Multicell), kanamycin monosulphate (25 μg/mL; Multicell), or 2% sucrose (Sigma-Aldrich) was added where indicated. Electrocompetent M. tuberculosis was prepared and electroporated as previously described [8] . For plasmid DNA cloning, the ElectroMAX DH5α-E competent Escherichia coli cells (Invitrogen) were used. All E. coli was grown in Luria-Bertani (LB) broth or on LB agar (BD Biosciences) with hygromycin (200 μg/mL) or gentamicin (5 μg/mL) (Multicell) where indicated.
Nucleic Acid Techniques
Mycobacterial DNA was extracted as previously described [9] and Southern blot and hybridization technique performed as previously described [10] . For confirmation of gene knockout by Southern blot, genomic DNA was digested with ClaI overnight and transferred to a Hybond-N nylon membrane (Amersham Biosciences) where it was hybridized with a 1.8-kbp polymerase chain reaction (PCR) amplicon probe of the namH gene.
Construction and Complementation of the M. tuberculosis namH Mutant
Gene knockout of namH was accomplished by a 2-step allelicexchange strategy using a thermosensitive sacB replicative vector as previously described [9] . In brief, a 210-bp fragment in the 5′ region of the namH gene was replaced by a hygromycin-resistance cassette. Further technical details and primers used are presented in Supplementary Figure 1C . The mutants were complemented with the functional namH gene under control of either the native or hsp60 promoter (see Supplementary Figure 1A for details).
Lipid Analysis
The extraction and analysis of polar lipids and mycolic acid containing glycolipids was performed following an adapted protocol from Slayden and Barry [11] . The mycolates were visualized by thin layer chromatography (TLC) analysis, by running the samples 3 times in a solvent system of hexanes and diethyl ether (Sigma-Aldrich) in a ratio of 85:15 (v/v).
Peptidoglycan Purification and High-Performance Liquid Chromatography Analysis
Mycobacterium tuberculosis strains were grown in a 500-mL volume of standard glycerol-supplemented 7H9 growth medium. Cultures at optical density readings at 600 nm (OD 600 ) 0.6-0.8 were centrifuged at 4°C and resuspended in 10 mL ice-cold H 2 O. The suspension was then added, drop by drop, to 10 mL of sterile 8% sodium dodecyl sulfate warmed to 100°C and then autoclaved at 121°C for 60 minutes to export them from the containment level 3 facility for further study. Samples were then processed for PGN extraction following a modified version of the protocol published by McNeil et al [12] . The HPLC fractionation and mass spectrometry were carried out as previously described by Veyrier et al [13] .
In Vitro Growth and Characterization of M. tuberculosis Bacterial cultures were grown to mid-exponential phase and adjusted to an OD 600 of 0.1, diluted 1:100 in 7H9 in a final volume of 50 mL, and allowed to grow for 13 days at 37°C with constant rolling. OD 600 measurements and plating for colonyforming units (CFU) was done every 2-3 days. On days 8, 11, and 13 the cultures were diluted 1:4 and later multiplied by a factor of 4 to obtain the undiluted OD 600 value.
Heat-killed bacteria from the mid-exponential growth phase were subject to 3 types of imaging using previously established protocols: Ziehl-Neelsen staining for the mycolic acids, fluoresceinlabeled vancomycin staining for the PGN [14] , and scanning electron microscopy [13] to assess the overall cell architecture.
Mice
The Nod2 −/− breeding colony and Nod2 +/+ littermate controls were established as previously described [15] . For survival studies, we used C57Bl/6-DBA2 F1 and Rag1 −/− mice (B6.129S7-Rag1 tm1Mom /J) from Jackson Laboratory. All mice were 6-12 weeks old, and experiments were conducted in accordance with the guidelines and regulations of the animal research ethics board of McGill University.
Ex Vivo Macrophage Stimulation and Infection Studies
Murine peritoneal macrophages were harvested from naive Nod2 +/+ and Nod2 −/− mice without prestimulation. A total of 10 5 cells per well were purified by adherence and cultured in 96-well plates for bacterial infection or stimulation with the indicated bacterial ligands. For bacterial survival studies, 4 hours postinfection the cells were washed 3 times with RPMI to eliminate extracellular bacteria, then macrophages were incubated in RPMI medium until sampling time. Culture supernatants were collected at designated intervals and stored at −20°C. TNF-α production by macrophages was assayed using enzyme-linked immunosorbent assay (ELISA; R&D Systems).
To obtain human monocyte-derived macrophages (MDMs), peripheral blood mononuclear cells were isolated, as described previously [16] , from heparinized blood from healthy donors using an approved protocol by the Ohio State University Institutional Review Board. Triplicate monolayers of 12-day-old MDMs in RHH medium (RPMI + HEPES + HSA) in a 24-well tissue culture plate were infected with a single cell suspension of M. tuberculosis strains at a multiplicity of infection (MOI) of 1:1, and incubated for 2 hours at 37°C/5% CO 2 [17] . Monolayers were washed and repleted with RPMI containing 2% serum and incubated for different timepoints (2, 24, 48, and 72 hours). Infected macrophages were then lysed and the lysates plated on 7H11 agar for counting CFUs at approximately 21 days as described [18] . Cell-free culture supernatants were harvested from the above experiment and used to determine TNF-α and interleukin 6 (IL-6) production by using an R&D ELISA kit.
Mouse Infection Studies
Seven-to 8-week old C57Bl/6 mice were aerosolized for 10 minutes using a Lovelace nebulizer (model 01-100, In-Tox Products) and 5 mice were killed 24 hours after each infection to determine the inoculum. Mice were killed at 1, 2, 3, 6, and 12 weeks postinfection for processing lungs and spleen, with the inclusion of Nod2 −/− mice for analysis at 3, 6, and 12 weeks.
The left (larger) lung was put in 10% neutral-buffered formalin for histopathologic analysis, and the right (smaller) lung and spleen were homogenized, serially diluted, and plated for enumeration of CFU. For long-term survival experiments, C57Bl/6-DBA2 F1 hybrids and Rag1 −/− mice were similarly aerosolized and mice were weighed weekly and monitored for their overall health status. Mice were humanely killed if they met prespecified criteria for weight loss or altered health status. Upon killing, lungs were harvested and kept in 10% neutral-buffered formalin for histopathologic verification of the cause of death.
Histopathology
Immediately following mouse killing, the left lung was put in 10% neutral-buffered formalin for at least 24 hours before being sent for processing (Histology Core Facility, Goodman Cancer Center, McGill University). Tissue was embedded in paraffin and 4-to 5-μm sections were processed for hematoxylin and eosin (H&E) staining.
Flow Cytometry Analysis
Single-cell suspensions were obtained from collagenase-and DNase-treated lungs. Cells were stained as previously described [19] using antibodies specific for mouse CD3, CD4, CD19, CD115, CD11c, F4/80, and Gr.1 (BD Biosciences). Flow cytometry was performed using a BD LSR II (BD Biosciences) instrument with FACSDiva Software Version 6.1.2 (BD Biosciences) and analysis was performed using FlowJo Software (Tree Star).
Figures and Statistics
Significant differences in ELISA, fluorescence-activated cell sorting (FACS), and CFU results were analyzed using the unpaired t test. For statistics involving CFU in mouse lungs and spleen, the standard error of the mean (SEM) were plotted and differences were deemed significant if P ≤ .05. Survival data were assigned P values based on the log-rank test. Figures were generated using GraphPad Prism version 4.0b (GraphPad Software).
Results
M. tuberculosis namH Mutant
Upon successful disruption of namH (Supplementary Figure 2A) , multiple independent isolates of the namH mutant were expanded in liquid media to test for loss of phthiocerol dimycocerosate (PDIM) (Supplementary Figure 2B) , a virulence factor that can be lost during in vitro culture on selective media [20] . Mutants positive for PDIM were retained for further analysis and complemented with 2 different integrative plasmids containing kanamycin-resistant cassettes, as confirmed by PCR.
To verify that disruption of namH in our strain affected PGN composition, we performed a direct analysis of the glycolylated and acetylated muropeptide molecules in the PGN. Mutanolysin was used to liberate disaccharides with varying peptide side-chains attached to the muramic moieties. As these peptide side-chains are extremely complex in mycobacteria, due to amidation [21] , we obtained a complex chromatogram ( Figure 1A ). As expected, the PGN from M. tuberculosis ΔnamH did not contain muropeptides composed of MurNGlyc (indicated by 1′, 2′, 3′, and 4′ in Figure 1A) , and for this reason the proportion of muropeptides composed of MurNAc (indicated with in Figure 1A ) were overrepresented. This phenotype was reversed by the addition of namH, under control of either the native or the artificial (hsp60) promoter.
Cell Wall Characterization
We first looked for differences in growth and morphology of the mutant and complemented strains compared to the wildtype (WT) strain. There was no difference between any of the 4 strains in terms of growth rate as measured by OD 600 ( Figure 1B) . As the 2 namH-complemented strains displayed no difference in growth ( Figure 1B) or apparent NamH activity ( Figure 1A) , we used M. tuberculosis complemented with namH under control of its native promoter for subsequent experiments.
We next investigated whether loss of the muramic acid modification would lead to gross structural differences in other parts of the mycobacterial cell wall given that the muramic acid we had modified serves as the anchor point for the arabinogalactan complex, itself linked to mycolic acids [22] . When assessing gross colony morphology on agar, there were no striking differences ( Figure 1C) . Likewise, assessment of bacterial morphology by scanning electron microscopy did not reveal any evident effect of NamH mutation ( Figure 1D ). When staining with vancomycin, known to reveal sites of peptidoglycan No obvious differences in the colony morphology were observed. Scale bar represents 1 cm. D, scanning electron microscopic imaging shows no observable differences in the size and shape of the bacteria. E, Vancomycin-FL staining shows no difference in nascent peptidoglycan synthesis between the wild-type and knockout strains, with both strains predominantly stained at the poles, which is consistent with the V-shaped or "snapping" model of mycobacterial growth previously reported [14] .
incorporation, as it targets the D-ala-D-ala motif, bacteria were primarily stained at the poles (Figure 1E) , consistent with the polar growth or snapping model of mycobacteria [14] ; again there were no differences in the staining patterns with namH disruption. Because the mycolic acids are indirectly attached to the muramic acid that we had modified, we assessed mycolates, by both Ziehl-Neelsen staining (data not shown) and TLC analysis (Supplementary Figure 2C) ; for both, there was no phenotypic difference with the namH mutant. Thus, we conclude that we had altered the muramic acid without generating a mutant with a grossly abnormal mycobacterial cell wall.
Ex Vivo Studies
Ex vivo stimulation of WT and Nod2
−/− mouse peritoneal macrophages with heat-killed M. tuberculosis, at an MOI of 2:1, demonstrated that NOD2-dependent TNF-α production was diminished in the absence of namH, and this could be genetically complemented (P < .005; Figure 2A ). To test whether this effect would be overcome when presenting a greater quantity of N-acetyl MDP, we repeated stimulation with an MOI of 100:1 ( Figure 2B) ; namH-dependent TNF-α production was again observed. To test whether namH disruption affects NOD2-mediated responses indirectly, eg, through altered presentation of other agonists to host pattern recognition receptors, we asked whether the introduction of 1 μg/mL N-glycolyl MDP could complement the phenotype seen with namH disruption. At both MOI of 2:1 and 100:1, TNF-α levels were restored with chemical complementation (Figures 2C and 2D) , indicating that N-glycolyl MDP directly contributes to the immunogenicity of killed M. tuberculosis, via NOD2. We proceeded to live bacterial infections to test for differences in survival and growth within primary macrophages. By infecting WT mouse peritoneal macrophages with M. tuberculosis at an MOI of 2:1 for a total duration of 7 days, we observed a slight increase in CFUs for both bacterial strains, with no difference between the WT and namH mutant strain ( Figure 3A) . Given that bacterial numbers were namH-independent, we assessed host TNF-α production. When compared to the findings from the heat-killed stimulations at the same MOI (Figure 2A) , live M. tuberculosis was associated with a markedly reduced cytokine response; however, TNF-α production was again namHdependent. In this case, chemical complementation with 1 μg/mL N-glycolyl MDP led to a significant, albeit incomplete, increase in TNF-α (P < .05; Figure 3B ).
To determine whether the namH-mediated alteration in M. tuberculosis PGN is also pertinent during infection of human cells, we repeated the above experiments in human monocyte-derived macrophages. As was seen in murine cells, Figure 2 . NOD2-mediated recognition of Mycobacterium tuberculosis (Mtb) by macrophages depends on bacterial namH. We tested the importance of namH disruption of M. tuberculosis during infection of primary macrophages and monitored the associated host cytokine response. A, Peritoneal macrophages from Nod2 +/+ and Nod2 −/− mice were harvested and adhesion purified, then infected with heat-killed wild-type, namH-deficient, or namHcomplemented M. tuberculosis at a multiplicity of infection (MOI) of 2:1. After 18 hours, the supernatant was collected and tumor necrosis factor alpha (TNF-α) levels were measured. B, Same experiment as A, with an MOI of 100:1. C, Peritoneal macrophages from Nod2 +/+ mice were infected with heatkilled wild-type M. tuberculosis or namH-deficient M. tuberculosis at an MOI of 2:1 with and without chemical complementation with 1 μg/mL N-glycolyl muramyl dipeptide (MDP). D, Same experiment as C, with an MOI of 100:1. Representative data from 2 independent replicates are shown (mean ± SEM). *P < .05; **P < .005. growth of M. tuberculosis was namH-independent ( Figure 4A ), but TNF-α production was diminished in the absence of namH (P < .005; Figure 4B ). In addition, IL-6 levels were measured at both 24 and 48 hours, and although no significant difference was attained there was a similar trend of reduced host response from the namH mutant strain ( Figure 4C ).
In Vivo Studies
Because NOD2 mediates both innate and adaptive immunity to M. tuberculosis [15] , we tested whether namH disruption would affect the course of in vivo infection. After aerosol infection of C57Bl/6 mice with approximately 30 CFUs of M. tuberculosis, bacterial numbers increased exponentially and peaked at 3 weeks postinfection ( Figure 5A ). WT M. tuberculosis, namH-deficient M. tuberculosis, and namH-complemented M. tuberculosis manifest an equivalent bacterial burden, both at the site of infection (lungs) and upon dissemination to the spleens. As bacterial numbers were namH-independent, we asked whether namH disruption would affect the host inflammatory response to an equivalent number of bacteria.
H&E stains of mouse lung sections at 3 weeks postinfection ( Figure 5B) show no qualitative differences between lungs infected with WT M. tuberculosis as compared to namH-deficient M. tuberculosis. To quantify the pulmonary host cellular responses, lungs of mice infected for 3 weeks were subject to FACS analysis. The total lung cellular response, including CD4 + and CD8 + lymphocytes as well as antigen-presenting cells (CD11c + dendritic cells and F4/80+ macrophages), were not significantly different ( Figure 5C ). In addition, we quantified cells positive for the tuberculosis-specific antigen TB10.4 and found no significant difference between mice infected with WT or namH mutant strains (data not shown). +/+ mice were infected with live WT M. tuberculosis and namH-deficient M. tuberculosis, at an MOI of 2:1, and chemically complemented with 1 μg/mL N-glycolyl muramyl dipeptide (MDP). Representative data from 2 independent replicates are shown (mean ± SEM). *P < .05; **P < .005. Figure 4 . NamH-dependent response to infection by human monocytederived macrophages. A, Monocyte-derived macrophages were infected with live wild-type Mycobacterium tuberculosis (Mtb), namH-deficient M. tuberculosis, and namH-complemented M. tuberculosis, at a multiplicity of infection of 1. The extracellular bacteria were washed away, the cells lysed, and the bacteria enumerated at 2, 24, 48, and 72 hours postinfection. The supernatants were collected and tumor necrosis factor alpha (TNF-α; B) or interleukin 6 (IL-6; C) levels were measured at 24 and 48 hours postinfection. Representative data from 2 independent replicates are shown (mean ± SEM). *P < .05; **P < .005. For the spleen, the bacteria were enumerated at 1, 2, 3, 6, and 12 weeks postinfection. Five mice were used per group. Representative data from 2 independent replicates are shown (mean ± SEM). B, Hematoxylin and eosin stain of mouse lung sections infected 3 weeks with the WT M. tuberculosis and namH-deficient M. tuberculosis. Lung pathology was examined to qualitatively describe any differences in lymphocyte recruitment or overall lung pathology. At 3 weeks postinfection we observed no difference in the nature of the gross pathologic response to infection between the 2 strains tested (lens magnification provided on each panel: 2.5× lens = ×25 total magnification). C, Lungs of C57BL/6 mice infected 3 weeks with WT M. tuberculosis and namH-deficient M. tuberculosis (KO) subject to fluorescence-activated cell sorting analysis to assess the cell populations present. By multiplying cell fractions against the total number of cells determined by hemocytometer counts, we quantified the number of CD4, CD8, CD11c, Gr1, F4/80, and CD115 cells present. No significant differences in cell numbers were observed.
Next, we tested whether the mutation of namH would affect host outcome in a long-term survival model. First, we used a host with an intact immune system, selecting the C57Bl/6-DBA2 F1 hybrid mice, as this strain is more susceptible to M. tuberculosis infection than regular C57Bl/6 mice [23] . In this model, we observed a trend toward improved survival with the namH mutant between days 120 and 180, but this trend then abruptly vanished ( Figure 6A ). To investigate differences at an earlier time point, when the innate response would predominate, we infected Rag1 −/− mice that lack an adaptive immune response. Here, mice infected with WT M. tuberculosis required compassionate sacrifice at a median time of 36 days postinfection, which was 2 weeks earlier than those infected with namHdeficient M. tuberculosis (log-rank test, P < .001; Figure 6B ). Mice infected with the namH-complemented M. tuberculosis strain had an intermediate phenotype that was significantly different from the namH-deficient strain (log-rank test, P < .003).
Thus overall, we conclude that the namH-deficient strain displayed variable effects on survival in the animal model, with at most a modest survival phenotype seen with Rag1 −/− mice.
DISCUSSION
In the current study, we have demonstrated not only that disruption of the namH gene in M. tuberculosis eliminates the presence of N-glycolated muropeptides in the PGN, but that the bacteria appeared otherwise unaltered and viable, providing us with a tool to study the importance of this modification for a host-adapted, human pathogen. Our results support and extend previously published findings with the avirulent bacterium M. smegmatis, revealing that the namH-mediated modification of the M. tuberculosis PGN contributes to its immunogenicity, and that the host response to this modification is mediated by NOD2. Using both genetic and chemical complementation, we conclusively showed that this altered immunogenicity of the mycobacterial cell wall is attributable to the presence of Nglycolyl MDP and that even at a high burden of infection, the absence of this molecule translates into significantly less immune stimulation. Similar findings were determined for both murine and human macrophages, which confirms that the Nglycolyl MDP/NOD2 interaction is relevant to the natural (human) host of M. tuberculosis. Interestingly, complete Freund's adjuvant is based on killed mycobacteria [5] and biochemical studies in the 1970s showed that its immunologic activity could be achieved by replacing the mycobacterial cell wall with MDP [24] . Our data showed that heat-killed M. tuberculosis is hyperimmunogenic compared to live M. tuberculosis, when using the same cellular preparations at the same bacterial burden. The increased activity of killed vs live mycobacteria may result from a greater release of both MDP and other pathogenassociated molecular patterns as a consequence of heat-killing the bacteria. An alternative hypothesis is that live mycobacteria actively dampen the host response [25] , a possibility supported by the observation that the addition of 1 μg/mL N-glycolyl MDP led to only partial complementation during live bacterial infection. These same bacteria allowed us to test whether altered interaction with host innate immunity affected the outcome of experimental M. tuberculosis infection. We did not detect differences in bacterial burden, immune responses, or survival with a long-term infection model. These findings indicate that even in the absence of namH, M. tuberculosis is able to direct an appropriate immune response and the bacterium is still capable of surviving and replicating in a mammalian host.
The unaltered survival of mice possessing an adaptive immune response may reflect the limitations of the model. It is already known that a bacteria with a 5-log reduced attack rate for people (bacillus Calmette Guérin) [26] only produces a 1-log reduction in numbers in the C57BL/6 mouse [27], Figure 6 . The effect of namH disruption on mouse survival after infection. A, C57Bl/6-DBA2 F1 hybrid mice (15 per group) were aerosol infected as previously described with wild-type (WT) Mycobacterium tuberculosis (Mtb), namH-deficient M. tuberculosis, and namH-complemented M. tuberculosis. There were no significant differences between the 3 strains used. B, Rag1
−/− mice (8 per group) were aerosol infected as previously described with WT M. tuberculosis, namH-deficient M. tuberculosis, and namH-complemented M. tuberculosis. Approximately 34 colony-forming units (CFU) were implanted into the lungs of the mice infected with the Mtb strain, 51 CFU for the ΔnamH strain, and 97 CFU for the ΔnamH: namH strain. There were significant differences between both WT M. tuberculosis vs namH-deficient M. tuberculosis (P < .001) and namH-deficient M. tuberculosis vs namH-complemented M. tuberculosis (P < .003).
suggesting that subtle shifts in bacterial growth (or virulence) may not be readily detectable in this system. Furthermore, investigations measuring a global phenotype after live M. tuberculosis infection may be limited by the complexity of numerous interwoven host-pathogen interactions, such that the absence of 1 receptor or its ligand, in isolation, may not produce a discernible effect. This possibility is supported by the literature on other pattern recognition receptors and M. tuberculosis, where isolated receptor-agonist studies have produced indisputable evidence of a host-pathogen dialogue, yet infection of mice disrupted for TLR2, MINCLE, and NOD2 has provided weakvariable phenotypes [28] [29] [30] . By extension, the effect of namH disruption might best be appreciated in a more indolent bacteria, that is, one that does not produce ESAT-6, punch holes in phagosomal membranes [31] , and thereby activate a number of host responses such as the cytosolic surveillance pathway [32] . Further studies, using different mycobacterial species, may be required to uncover the biological utility of this cell wall modification for mycobacteria and related Actinomycetes, and to determine the species of mycobacteria where NOD2-mediated recognition of modified PGN is most critical.
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